Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution (VaMPiRE)

NCT06941012 is registered in ClinicalTrials.gov with Casa di Cura IGEA as lead sponsor.

NCT NCT06941012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06941012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution (VaMPiRE)
Lead sponsor
Casa di Cura IGEA
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2025
Completion date
April 30, 2029
Enrollment
1,200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (pd)